{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:10:28Z","timestamp":1790266228322,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00467-026-07431-2","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:23:20Z","timestamp":1782440600000},"page":"4155-4164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acetazolamide-induced metabolic acidosis in pediatric idiopathic intracranial hypertension: associations with bone mineral density, growth, and kidney function"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-4905","authenticated-orcid":false,"given":"Demet","family":"Baltu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7640-2469","authenticated-orcid":false,"given":"Nesrin","family":"Ta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-5280","authenticated-orcid":false,"given":"Nurettin","family":"Al\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-9324","authenticated-orcid":false,"given":"Arzu","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"7431_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.spen.2017.04.002","volume":"24","author":"CA Sheldon","year":"2017","unstructured":"Sheldon CA, Paley GL, Beres SJ, McCormack SE, Liu GT (2017) Pediatric pseudotumor cerebri syndrome: diagnosis, classification, and underlying pathophysiology. Semin Pediatr Neurol 24:110\u2013115. https:\/\/doi.org\/10.1016\/j.spen.2017.04.002","journal-title":"Semin Pediatr Neurol"},{"key":"7431_CR2","doi-asserted-by":"publisher","first-page":"F366","DOI":"10.1152\/ajprenal.00501.2019","volume":"319","author":"P Alam","year":"2020","unstructured":"Alam P, Amlal S, Thakar CV, Amlal H (2020) Acetazolamide causes renal HCO3\u2212 wasting but inhibits ammoniagenesis and prevents the correction of metabolic acidosis by the kidney. Am J Physiol Renal Physiol 319:F366-f379. https:\/\/doi.org\/10.1152\/ajprenal.00501.2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"7431_CR3","doi-asserted-by":"publisher","first-page":"F517","DOI":"10.1152\/ajprenal.00494.2013","volume":"306","author":"JA Gasser","year":"2014","unstructured":"Gasser JA, Hulter HN, Imboden P, Krapf R (2014) Effect of chronic metabolic acidosis on bone density and bone architecture in vivo in rats. Am J Physiol Renal Physiol 306:F517. https:\/\/doi.org\/10.1152\/ajprenal.00494.2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"7431_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/WNO.0000000000000322","volume":"36","author":"MW ten Hove","year":"2016","unstructured":"ten Hove MW, Friedman DI, Patel AD, Irrcher I, Wall M, McDermott MP (2016) Safety and tolerability of acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol 36:13\u201319. https:\/\/doi.org\/10.1097\/WNO.0000000000000322","journal-title":"J Neuroophthalmol"},{"key":"7431_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/WNO.0000000000000330","volume":"36","author":"JN Au","year":"2016","unstructured":"Au JN, Waslo CS, McGwin G Jr, Huisingh C, Tanne E (2016) Acetazolamide-induced nephrolithiasis in idiopathic intracranial hypertension patients. J Neuroophthalmol 36:126\u2013130. https:\/\/doi.org\/10.1097\/WNO.0000000000000330","journal-title":"J Neuroophthalmol"},{"key":"7431_CR6","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1210\/jc.2011-1111","volume":"96","author":"BS Zemel","year":"2011","unstructured":"Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96:3160\u20133169. https:\/\/doi.org\/10.1210\/jc.2011-1111","journal-title":"J Clin Endocrinol Metab"},{"key":"7431_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4274\/jcrpe.2183","volume":"7","author":"O Neyzi","year":"2015","unstructured":"Neyzi O, Bundak R, G\u00f6k\u00e7ay G, G\u00fcn\u00f6z H, Furman A, Darendeliler F, Ba\u015f F (2015) Reference values for weight, height, head circumference, and body mass index in Turkish children. J Clin Res Pediatr Endocrinol 7:280\u2013293. https:\/\/doi.org\/10.4274\/jcrpe.2183","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"7431_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637. https:\/\/doi.org\/10.1681\/ASN.2008030287","journal-title":"J Am Soc Nephrol"},{"key":"7431_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-025-06785-3","author":"G Florio","year":"2025","unstructured":"Florio G, Bockenhauer D (2025) When our treatment is complicated: an overview of drug-induced acid-base disorders: part 1-acidosis. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-025-06785-3","journal-title":"Pediatr Nephrol"},{"key":"7431_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00467-023-06084-9","volume":"39","author":"Y Bulkowstein","year":"2024","unstructured":"Bulkowstein Y, Nitzan-Luques A, Schnapp A, Barnoy N, Reif S, Gilboa T, Volovesky O (2024) The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension. Pediatr Nephrol 39:185\u2013191. https:\/\/doi.org\/10.1007\/s00467-023-06084-9","journal-title":"Pediatr Nephrol"},{"key":"7431_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF02556624","volume":"40","author":"GE Hall","year":"1987","unstructured":"Hall GE, Kenny AD (1987) Role of carbonic anhydrase in bone resorption: effect of acetazolamide on basal and parathyroid hormone-induced bone metabolism. Calcif Tissue Int 40:212\u2013218. https:\/\/doi.org\/10.1007\/BF02556624","journal-title":"Calcif Tissue Int"},{"key":"7431_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/jbmr.5650060406","volume":"6","author":"WM Pierce Jr.","year":"1991","unstructured":"Pierce WM Jr., Nardin GF, Fuqua MF, Sabah-Maren E, Stern SH (1991) Effect of chronic carbonic anhydrase inhibitor therapy on bone mineral density in white women. J Bone Miner Res 6:347\u2013354. https:\/\/doi.org\/10.1002\/jbmr.5650060406","journal-title":"J Bone Miner Res"},{"key":"7431_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5582\/irdr.2016.01067","volume":"5","author":"JD Gonz\u00e1lez-Rodr\u00edguez","year":"2016","unstructured":"Gonz\u00e1lez-Rodr\u00edguez JD, Luis-Yanes MI, Ingl\u00e9s-Torres E, Arango-Sancho P, Cabrera-Sevilla JE, Duque-Fern\u00e1ndez MR, Gil-S\u00e1nchez S, Garc\u00eda-Nieto VM (2016) Can acetazolamide be used to treat diseases involving increased bone mineral density? Intractable Rare Dis Res 5:284\u2013289. https:\/\/doi.org\/10.5582\/irdr.2016.01067","journal-title":"Intractable Rare Dis Res"},{"key":"7431_CR14","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1046\/j.1523-1755.2000.00086.x","volume":"57","author":"J Green","year":"2000","unstructured":"Green J, Maor G (2000) Effect of metabolic acidosis on the growth hormone\/IGF-I endocrine axis in skeletal growth centers. Kidney Int 57:2258\u20132267. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00086.x","journal-title":"Kidney Int"},{"key":"7431_CR15","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/ndt\/gfh096","volume":"19","author":"MR Wiederkehr","year":"2004","unstructured":"Wiederkehr MR, Kalogiros J, Krapf R (2004) Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 19:1190\u20131197. https:\/\/doi.org\/10.1093\/ndt\/gfh096","journal-title":"Nephrol Dial Transplant"},{"key":"7431_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s0887-8994(96)00228-7","volume":"15","author":"Y Futagi","year":"1996","unstructured":"Futagi Y, Otani K, Abe J (1996) Growth suppression in children receiving acetazolamide with antiepileptic drugs. Pediatr Neurol 15:323\u2013326. https:\/\/doi.org\/10.1016\/s0887-8994(96)00228-7","journal-title":"Pediatr Neurol"},{"key":"7431_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3129\/i09-198","volume":"45","author":"S Sharan","year":"2010","unstructured":"Sharan S, Dupuis A, H\u00e9bert D, Levin AV (2010) The effect of oral acetazolamide on weight gain in children. Can J Ophthalmol 45:41\u201345. https:\/\/doi.org\/10.3129\/i09-198","journal-title":"Can J Ophthalmol"},{"key":"7431_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2022.1042529","volume":"2","author":"CA Sheldon","year":"2022","unstructured":"Sheldon CA, Reggie SN, Paley GL, McCormack SE, Liu GT (2022) Effects of acetazolamide on linear growth in children with pseudotumor cerebri syndrome. Front Ophthalmol 2:1042529. https:\/\/doi.org\/10.3389\/fopht.2022.1042529","journal-title":"Front Ophthalmol"},{"key":"7431_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/WNO.0000000000002307","volume":"45","author":"J Muayad","year":"2025","unstructured":"Muayad J, Alryalat SA, Al Deyabat O, Loya A, Lee AG (2025) Assessing the risk of kidney stone development in patients with idiopathic intracranial hypertension treated with carbonic anhydrase inhibitors. J Neuroophthalmol 45:420\u2013425. https:\/\/doi.org\/10.1097\/WNO.0000000000002307","journal-title":"J Neuroophthalmol"},{"key":"7431_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1681\/ASN.0000000515","volume":"36","author":"C Ginsberg","year":"2025","unstructured":"Ginsberg C, Seegmiller JC, Vallon V, Jin SS, Thomas RL, Boeder SC, Pettus J, Ix JH (2025) Acetazolamide therapy and kidney function in persons with nonalbuminuric diabetes mellitus type 1. J Am Soc Nephrol 36:463\u2013470. https:\/\/doi.org\/10.1681\/ASN.0000000515","journal-title":"J Am Soc Nephrol"},{"key":"7431_CR21","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, Tartaglia K, Chenot F, Moubayed S, Dierckx R, Blouard P, Troisfontaines P, Derthoo D, Smolders W, Bruckers L, Droogne W, Ter Maaten JM, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M (2022) Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 387:1185\u20131195. https:\/\/doi.org\/10.1056\/NEJMoa2203094","journal-title":"N Engl J Med"},{"key":"7431_CR22","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.16526","volume":"133","author":"A Kosiorek","year":"2023","unstructured":"Kosiorek A, Urban S, Detyna J, Biegus J, Hurkacz M, Zymli\u0144ski R (2023) Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study. Pol Arch Intern Med 133:16526. https:\/\/doi.org\/10.20452\/pamw.16526","journal-title":"Pol Arch Intern Med"},{"key":"7431_CR23","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1681\/ASN.0000000731","volume":"36","author":"H Ito","year":"2025","unstructured":"Ito H, Mori T (2025) Acetazolamide and renal hemodynamics: interplay between tubuloglomerular feedback and renin-angiotensin-aldosterone system adaptation. J Am Soc Nephrol 36:1450\u20131451. https:\/\/doi.org\/10.1681\/ASN.0000000731","journal-title":"J Am Soc Nephrol"},{"key":"7431_CR24","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.931319","volume":"22","author":"RM Abou-Mrad","year":"2021","unstructured":"Abou-Mrad RM, Ibrahim M, Osman N, Babu RS (2021) Anuric acute kidney injury requiring dialysis following acetazolamide use for cataract surgery. Am J Case Rep 22:e931319. https:\/\/doi.org\/10.12659\/AJCR.931319","journal-title":"Am J Case Rep"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07431-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07431-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07431-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:35:15Z","timestamp":1790264115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07431-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["7431"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07431-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was obtained from the Ethics Committee of Ankara Research and Training Hospital.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}